Report Detail

Global Companion Diagnostics Market 2020 By Products & Services [Assays, Kits, & Reagents, Software & Services and others],By Indication [Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases and Others,], By End User[Pharmaceutical Companies, Contract Research Organizations, Laboratories and Others], By Technology[Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS) and Others]: Global Forecast to 2026 and COVID-19 Impact Outlook
Companion Diagnostics Market is valued at USD 2.01 Billion in 2019 and expected to reach USD 6.76 Billion by 2026 with the CAGR of 19.03% over the forecast period.

Scope of the report
This report analyses the global market for Companion Diagnostics . The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.

Key Players
F. Hoffmann-La Roche AG,ARUP Laboratories,Myriad Genetics, Inc.,Thermo Fisher Scientific Inc.,Agilent Technologies,Abbott Laboratories,Qiagen N.V and others
Above mentioned companies were scrutinized to assess competitive landscape of global Companion Diagnostics market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.

Review period:
(2016-2026)
Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Billion
This Companion Diagnostics market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.

Regions

• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa

Market Segmentation


• Products & Services
o Assays, Kits, & Reagents
o Software & Services
• Indication
o Cancer
o Neurological Diseases
o Infectious Diseases
o Cardiovascular Diseases
o Others
• End User
o Pharmaceutical Companies
o Contract Research Organizations
o Laboratories
o Others
• Technology
o Polymerase Chain Reaction (PCR)
o In Situ Hybridization (ISH)
o Immunohistochemistry (IHC)
o Next-Generation Sequencing (NGS)
o Others

Report Coverage

• An overview of the global Companion Diagnostics market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Companion Diagnostics market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Companion Diagnostics market
• Market share analysis of key market participants and their competitive landscape

Important Questions Answered by Global Companion Diagnostics Market Report
• What is the impact of COVID 19 epidemic on the global Companion Diagnostics market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Companion Diagnostics market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Companion Diagnostics market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?


Table of Contents

    1. Introduction

    • 1.1. Report Description
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. List of Abbreviations

    2. Executive Summary

      3. Market Overview

      • 3.1. Market Definition
      • 3.2. Market Scope
      • 3.3. Market Drivers
      • 3.4. Market Restraints
      • 3.5. Market Opportunities and Trends
      • 3.6. Porter’s five force analysis
      • 3.7. SWOT Analysis
      • 3.8. PEST Analysis
      • 3.9. Patent Analysis
      • 3.10. Impact of COVID 19 on Global Companion Diagnostics Market

      4. Companion Diagnostics Market, By Products & Services, Market Size and Forecast 2016 -2026 (USD Billion)

      • 4.1. Global Companion Diagnostics Market By Products & Services, 2016 -2026 (USD Billion)
        • 4.1.1. Global Companion Diagnostics Market By Assays, Kits, & Reagents
        • 4.1.2. Global Companion Diagnostics Market By Software & Services
      • 4.2. Global Companion Diagnostics Market By Products & Services Share, 2016 -2026 (%)

      5. Companion Diagnostics Market, By End User, Market Size and Forecast 2016 -2026 (USD Billion)

      • 5.1. Global Companion Diagnostics Market By End User, 2016 -2026 (USD Billion)
        • 5.1.1. Global Companion Diagnostics Market By Pharmaceutical Companies
        • 5.1.2. Global Companion Diagnostics Market By Contract Research Organizations
        • 5.1.3. Global Companion Diagnostics Market By Laboratories
        • 5.1.4. Global Companion Diagnostics Market By Others
      • 5.2. Global Companion Diagnostics Market By End User Share, 2016 -2026 (%)

      6. Companion Diagnostics Market, By Indication, Market Size and Forecast 2016 -2026 (USD Billion)

      • 6.1. Global Companion Diagnostics Market By Indication, 2016 -2026 (USD Billion)
        • 6.1.1. Global Companion Diagnostics Market By Cancer
        • 6.1.2. Global Companion Diagnostics Market By Neurological Diseases
        • 6.1.3. Global Companion Diagnostics Market By Infectious Diseases
        • 6.1.4. Global Companion Diagnostics Market By Cardiovascular Diseases
        • 6.1.5. Global Companion Diagnostics Market By Others
      • 6.2. Global Companion Diagnostics Market By Indication Share, 2016 -2026 (%)

      7. Companion Diagnostics Market, By Technology, Market Size and Forecast 2016 -2026 (USD Billion)

      • 7.1. Global Companion Diagnostics Market By Technology, 2016 -2026 (USD Billion)
        • 7.1.1. Global Companion Diagnostics Market By Polymerase Chain Reaction (PCR)
        • 7.1.2. Global Companion Diagnostics Market By In Situ Hybridization (ISH)
        • 7.1.3. Global Companion Diagnostics Market By Immunohistochemistry (IHC)
        • 7.1.4. Global Companion Diagnostics Market By Next-Generation Sequencing (NGS)
        • 7.1.5. Global Companion Diagnostics Market By Others
      • 7.2. Global Companion Diagnostics Market By Technology Share, 2016 -2026 (%)

      8. Companion Diagnostics Market, By Region Market Size and Forecast 2016 -2026

      • 8.1. NORTH AMERICA
        • 8.1.1. Key Findings
        • 8.1.2. Impact of COVID 19
        • 8.1.3. Key market trends, growth factors and opportunities
        • 8.1.4. North America Companion Diagnostics Market by Country 2016 -2026 (USD Billion)
        • 8.1.5. North America Companion Diagnostics Market By Products & Services 2016 -2026 (USD Billion)
        • 8.1.6. North America Companion Diagnostics Market By Indication 2016 -2026 (USD Billion)
        • 8.1.7. North America Companion Diagnostics Market By End User 2016 -2026 (USD Billion)
        • 8.1.8. North America Companion Diagnostics Market By Technology 2016 -2026 (USD Billion)
      • 8.2. EUROPE
        • 8.2.1. Key Findings
        • 8.2.2. Impact of COVID 19
        • 8.2.3. Key market trends, growth factors and opportunities
        • 8.2.4. Europe Companion Diagnostics Market by Country 2016 -2026 (USD Billion)
        • 8.2.5. Europe Companion Diagnostics Market By Products & Services 2016 -2026 (USD Billion)
        • 8.2.6. Europe Companion Diagnostics Market By Indication 2016 -2026 (USD Billion)
        • 8.2.7. Europe Companion Diagnostics Market By End User 2016 -2026 (USD Billion)
        • 8.2.8. Europe Companion Diagnostics Market By Technology 2016 -2026 (USD Billion)
      • 8.3. ASIA PACIFIC
        • 8.3.1. Key Findings
        • 8.3.2. Impact of COVID 19
        • 8.3.3. Key market trends, growth factors and opportunities
        • 8.3.4. Asia Pacific Companion Diagnostics Market by Country 2016 -2026 (USD Billion)
        • 8.3.5. Asia Pacific Companion Diagnostics Market By Products & Services 2016 -2026 (USD Billion)
        • 8.3.6. Asia Pacific Companion Diagnostics Market By Indication 2016 -2026 (USD Billion)
        • 8.3.7. Asia Pacific Companion Diagnostics Market By End User 2016 -2026 (USD Billion)
        • 8.3.8. Asia Pacific Companion Diagnostics Market By Technology 2016 -2026 (USD Billion)
      • 8.4. LATIN AMERICA
        • 8.4.1. Key Findings
        • 8.4.2. Impact of COVID 19
        • 8.4.3. Key market trends, growth factors and opportunities
        • 8.4.4. Latin America Companion Diagnostics Market by Country 2016 -2026 (USD Billion)
        • 8.4.5. Latin America Companion Diagnostics Market By Products & Services 2016 -2026 (USD Billion)
        • 8.4.6. Latin America Companion Diagnostics Market By Indication 2016 -2026 (USD Billion)
        • 8.4.7. Latin America Companion Diagnostics Market By End User 2016 -2026 (USD Billion)
        • 8.4.8. Latin America Companion Diagnostics Market By Technology 2016 -2026 (USD Billion)
      • 8.5. MIDDLE EAST AND AFRICA
        • 8.5.1. Key Findings
        • 8.5.2. Impact of COVID 19
        • 8.5.3. Key market trends, growth factors and opportunities
        • 8.5.4. Middle East and Africa Companion Diagnostics Market by Country 2016 -2026 (USD Billion)
        • 8.5.5. Middle East and Africa Companion Diagnostics Market By Products & Services 2016 -2026 (USD Billion)
        • 8.5.6. Middle East and Africa Companion Diagnostics Market By Indication 2016 -2026 (USD Billion)
        • 8.5.7. Middle East and Africa Companion Diagnostics Market By End User 2016 -2026 (USD Billion)
        • 8.5.8. Middle East and Africa Companion Diagnostics Market By Technology 2016 -2026 (USD Billion)

      9. Competitive Landscape Analysis

      • 9.1. Global Companion Diagnostics Market Company Revenue, (USD Billion), 2016-2019
      • 9.2. Global Companion Diagnostics Market Company Share, (%), 2016-2019

      10. Company Profiles

      • 10.1. F. Hoffmann-La Roche AG
      • 10.2. ARUP Laboratories
      • 10.3. Myriad Genetics, Inc.
      • 10.4. Thermo Fisher Scientific Inc.
      • 10.5. Agilent Technologies
      • 10.6. Abbott Laboratories
      • 10.7. Qiagen N.V.
      • 10.8. Others

      11. Appendix

        12. List of Tables

          13. List of Figures

          Summary:
          Get latest Market Research Reports on Companion Diagnostics . Industry analysis & Market Report on Companion Diagnostics is a syndicated market report, published as Global Companion Diagnostics Market By Products & Services [Assays, Kits, & Reagents, Software & Services and others],By Indication [Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases and Others,], By End User[Pharmaceutical Companies, Contract Research Organizations, Laboratories and Others], By Technology[Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS) and Others]: Market Research Report 2021 . It is complete Research Study and Industry Analysis of Companion Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

          Last updated on

          REPORT YOU MIGHT BE INTERESTED

          Purchase this Report

          $3,785.00
          $4,800.00
          $6,580.00
          2,986.37
          3,787.20
          5,191.62
          3,591.96
          4,555.20
          6,244.42
          590,876.35
          749,328.00
          1,027,203.80
          319,718.95
          405,456.00
          555,812.60
          Credit card Logo

          Related Reports


          Reason to Buy

          Request for Sample of this report